The judges looked for a track record of fundraising between April 2017 – April 2018 An impressive level of investment and exits achieved during the period A reputation for providing valuable strategic and commercial advice to portfolio companies A strong financial return for private investors
The company’s insulin and glucagon products, which are set to transform diabetes treatments, could have peak annual sales of between $200 million and $1 billion each.
Their mission is to connect healthcare systems around the world, making communication secure, transparent and flexible for healthcare professionals and patients.
Orchard Therapeutics is a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies
Hazy offers a unique platform that allows businesses to share data responsibly and securely through a workflow tool, automatically anonymises and adapting to changing datasets.
Quantexa now boasts a workforce of over 90 and engagements with some of the world’s largest organisations
Phrasee is world-leading AI that generates and optimises marketing copy at scale, delivering improved results for email subject lines, push notifications, and Facebook and Instagram ads.